These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8194380)

  • 1. Apolipoprotein (a) phenotypes in cardio-cerebrovascular diseases.
    Zhuang YY; Li JJ; Wang JJ
    Chin Med J (Engl); 1994 Feb; 107(2):133-6. PubMed ID: 8194380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Apolipoprotein (a) phenotypes of patients with myocardial infarction].
    Zhong Y; Li J; Wang J
    Zhonghua Yi Xue Za Zhi; 1995 Mar; 75(3):149-51; 190. PubMed ID: 7780820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) phenotypes in cardio-cerebrovascular diseases.
    Zhuang Y; Li J; Wang J
    Chem Phys Lipids; 1994 Jan; 67-68():293-7. PubMed ID: 8187226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apolipoprotein(a) and cortical cerebral infarction].
    Zhang Y; Liang X
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):350-3. PubMed ID: 10923438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
    Liu X; Sun L; Li Z; Gao Y; Hui R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein(a) isoforms in infarcted men under 60 years old.
    Calmarza P; Cordero J; Santos V; Vella JC
    Clin Biochem; 2004 Oct; 37(10):911-8. PubMed ID: 15369723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
    Shi H; Fang J; Yang X; Shen Z; Zhu X
    Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Montagna L; Falcone C; Geroldi D
    Clin Chim Acta; 2004 Dec; 350(1-2):159-65. PubMed ID: 15530473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein(a) and cortical cerebral infarction.
    Yingdong Z; Xiuling L
    Chin Med Sci J; 1999 Dec; 14(4):249-54. PubMed ID: 12894903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apo(a) phenotype as a risk factor for the silent brain infarction].
    Notsu Y; Nabika T; Masuda J; Kobayashi S
    Rinsho Byori; 1997 Feb; 45(2):122-6. PubMed ID: 9120995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased lipoprotein (a) as an independent risk factor for cardiovascular and cerebrovascular diseases.
    Zhuang YY; Wang JJ; Xu P
    Chin Med J (Engl); 1993 Aug; 106(8):597-600. PubMed ID: 8222908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency distributions of plasma apolipoprotein(a) levels and phenotypes: a comparison between southern and northern Chinese populations.
    Pang RW; Chen B; Janus ED; Lam KS
    Chin Med J (Engl); 1997 Jun; 110(6):465-73. PubMed ID: 9594249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma level of Lp(a) in patients with myocardial infarct is not controlled by the apolipoprotein E gene polymorphism].
    Hubácek JA; Stávek P; Pit'ha J; Skodová Z; Poledne R
    Cas Lek Cesk; 2001 Jun; 140(11):332-4. PubMed ID: 11431852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoprotein(a) and apolipoprotein(a) phenotypes in patients with rheumatoid arthritis.
    Asanuma Y; Kawai S; Aoshima H; Kaburaki J; Mizushima Y
    Arthritis Rheum; 1999 Mar; 42(3):443-7. PubMed ID: 10088766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
    Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
    Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
    Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
    Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination and clinical significance of lipoprotein(a) in cardio-cerebrovascular diseases].
    Zhuang Y
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):162-4, 191. PubMed ID: 1319809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
    Simó JM; Joven J; Vilella E; Ribas M; Pujana MA; Sundaram IM; Hammel JP; Hoover-Plow JL
    Thromb Haemost; 2001 Mar; 85(3):412-7. PubMed ID: 11307806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
    Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.